However, the expression of other CSC markers identified in serous ovarian cancer cells [46] including PROM1 (CD133) and CD44 were not affected by 4-MU treatment in spheroids formed by the primary serous ovarian cancer cells. The gene discussed is CD44; the disease is ovarian serous adenocarcinoma.